Astria Biosciences, Inc.
PrivateLast Round
Accelerator
Feb 27, 2025
Total Funding Raised
$440,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Astria Biosciences, Inc. is a biotechnology company that develops non-invasive blood-based diagnostic and therapeutic solutions for cerebrovascular diseases, including cerebral aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astria Biosciences, Inc. Comparables
Compare Astria Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurovascular Diagnostics | 85% | |
| Ischemia Care | 71% | |
| BrainDTech | 62% |
Astria Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 27, 2025 | ||||
| Grant | Oct 18, 2024 | ||||
| Grant | Sep 4, 2024 | ||||
| Grant | Nov 21, 2023 |
Astria Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab | Accelerator |
| Innovation Works | Accelerator, Grant |
| The BNY Mellon Foundation of Southwestern Pennsylvania | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 413% MoM.
- Mar 2, 2026
Monthly visitors increased 35% MoM.
Astria Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Astria Biosciences, Inc.'s valuation, stock price, and market status.
Is Astria Biosciences, Inc. a public or private company?
Astria Biosciences, Inc. is a private company.
What is the current stock price of Astria Biosciences, Inc.?
Astria Biosciences, Inc. is a private company with no public stock price. Caplight tracks Astria Biosciences, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Astria Biosciences, Inc. worth (valuation)?
Valuation information for Astria Biosciences, Inc. is not publicly available.
Can I buy Astria Biosciences, Inc. stock?
Astria Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Astria Biosciences, Inc.'s last funding round?
Astria Biosciences, Inc.'s most recent funding round was Accelerator on February 27, 2025.
Who are the main investors in Astria Biosciences, Inc.?
Key investors in Astria Biosciences, Inc. include AlphaLab, Innovation Works, The BNY Mellon Foundation of Southwestern Pennsylvania, National Science Foundation.
Will Astria Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Astria Biosciences, Inc..
How can I track Astria Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Astria Biosciences, Inc.'s secondary market activity and sign up for updates.